Sponsor

Nexbiome Therapeutics

France 22 Allee Alan Turing, 63000 Clermont Ferrand, France

About the sponsor

Nexbiome Therapeutics focuses on gynaecological conditions involving acute vaginal infection, with research activity centered on women diagnosed with bacterial vaginosis, vulvovaginal candidiasis, and mixed infectious presentations.

Bacterial vaginosis
Vulvovaginal candidiasis
Mixed vaginal infection

The sponsor’s current clinical activity is directed toward treatment options for symptomatic vaginal dysbiosis and infection in women.

About Specializations

Nexbiome Therapeutics runs clinical trials in conditions such as Vaginal infection, among others.

Vaginal infection

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Vaginal infection

Not recruiting

Investigational

Study on the Effectiveness and Safety of BGY-1601-VT for Women with Acute Vaginal Infections, Including Bacterial Vaginosis and Yeast Infections

Investigational

France

Participants:18–64 years
Substances:Lactobacillus Rhamnosus, Strain Lcr35, Live
Sponsor:Nexbiome Therapeutics

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →